|Day Low/High||0.98 / 1.02|
|52 Wk Low/High||0.97 / 1.81|
Walk to End Alzheimer's is Largest Fundraiser Dedicated to Alzheimer's Care, Support and Research Programs
Investors considering a purchase of Genesis Healthcare Inc stock, but tentative about paying the going market price of $3.33/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $2.50 strike, which has a bid at the time of this writing of 15 cents.
Important Clinical Collaboration between Genesis HealthCare and UNM Health System
News of Intesa's potential takeover bid extended Generali's three-day gains to 15%.
Paul Bach Named Successor Chief Operating Officer
In recent trading, shares of Genesis Healthcare Inc have crossed above the average analyst 12-month target price of $2.67, changing hands for $2.72/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
- NueHealth Patients Now Have Access to Advanced Early Cancer Detection Tests -
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against Genesis Healthcare, Inc.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.